Elham Mohit

7PUBLICATIONS
1CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Infectious agents
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 24, 2026
Immunotherapy Treatment of Colorectal Cancer and Lung Metastasis with Genetically Modified Outer Membrane Vesicles Delivering Poly-Neoepitopes in a Mouse Model.

|Jul 03, 2024
In Silico Design of CT26 Polytope and its Surface Display by ClearColi™-Derived Outer Membrane Vesicles as a Cancer Vaccine Candidate Against Colon Carcinoma.

Elham Sharif, Navid Nezafat, Fatemeh Maghsood Ahmadi

|Mar 14, 2024
Preparation, Characterization, and Radiolabeling of Anti-HER2 scFv With Technetium Tricarbonyl and Stability Studies.

Negar Bozorgchami, Maryam Ahmadzadeh, Dara Hatamabadi

|Jan 17, 2023
Therapeutic potential of a novel IP-10-(anti-HER2 scFv) fusion protein for the treatment of HER2-positive breast cancer.

Maryam Ahmadzadeh, Elham Mohit

|Jan 21, 2022
Different strategies for expression and purification of the CT26-poly-neoepitopes vaccine in Escherichia coli.

Zahra Movahed, Elham Sharif, Maryam Ahmadzadeh

|Mar 09, 2021
The Effect of Growth Stage and Isolation Method on Properties of ClearColi™ Outer Membrane Vesicles (OMVs).

Elham Sharif, Zohre Eftekhari, Elham Mohit

Pageof 2

Frequent Collaborators

1 joint publications

Soraya Shahhosseini